Cancer Biology

Discussions of New Developments and Updates

Skip to content
  • Home
  • About
  • Topics
    • Statistics & Epidemiology
      • Incidence
      • Mortality
      • Prevention
      • Diet & Nutrition
    • Biology
      • Cell Cycle
      • Tumor Microenvironment
      • Angiogenesis
      • Invasion & Metastasis
      • Immortalization
      • Stem Cells
      • Heterotypic Cellular Interactions
    • Signal Transduction
      • Receptor Tyrosine Kinase Inhibitors
      • Hormone Receptors
      • Growth Receptors
    • Genetics
      • Oncogenes
      • Tumor Suppressor Genes
      • Mutations
      • Epigenetic Regulation
      • DNA Repair
    • Immunology & Immunotherapy
      • Antibodies & Conjugates
      • Checkpoint Inhibitors
      • Vaccines
      • CAR-T
    • Therapy
      • Traditional Chemotherapy
      • Hormonal
      • Surgery & Radiation
      • Rational Drug Design
      • Off-Target Effects
      • Pharmacokinetics & Pharmacodynamics
      • Resistance
  • SHU Department of Biology
Cancer Biology

Tag Archives: classical Hodgkin lymphoma

PD-L1 Inhibitor, avelumab, approved for Merkel cell carcinoma

Avelumab (Bavencio) is a PD-L1 inhibitor that was approved for the treatment of patients with metastatic Merkel cell carcinoma (MCC). Continue reading →

This entry was posted in active immunotherapy, Checkpoint Inhibitors, Immunology & Immunotherapy, Mutations, Tumor Suppressor Genes, Uncategorized and tagged atrezolizumab, avelumab, Bavencio, bladder cancer, checkpoint inhibitor, classical Hodgkin lymphoma, darvalumab, gastric cancer, HCC, hepatocellular carcinoma, HNSCC, Keytruda, MCPyV, MCV, MEDI4736, melanoma, Merkel cell carcinoma, Merkel cell polyomavirus, nivolumab, non-small cell lung cancer, NSCLC, Opdivo, PD-L1, Pembrolizumab, Renal cell carcinoma, squamous cell carcinoma of the head and neck, Tecentriq on April 5, 2017 by Joseph Gulfo.


This blog is designed to provide updates in developments in cancer biology and engage in discussions about new findings in the field.

Sponsored by the Department of Biology, Seton Hall University.

@josephgulfo

Joseph Gulfo, MD Joseph Gulfo, MD ·
@josephgulfo
Opinion | Prior Authorization Is Hurting Our Patients https://t.co/ETTFWWWwZi
View on Twitter
0
0
Joseph Gulfo, MD Joseph Gulfo, MD ·
@josephgulfo
Artist Projects American Flag onto Swiss Alps: ‘God Bless America‘ https://t.co/vXcFilN8f5 via @BreitbartNews
View on Twitter
0
0
Joseph Gulfo, MD Joseph Gulfo, MD ·
@josephgulfo
Thoughtful FedEx Driver Sanitizes Package for Immunocompromised Girl https://t.co/iiFsybDcvP via @BreitbartNews
View on Twitter
0
2
Joseph Gulfo, MD Joseph Gulfo, MD ·
@josephgulfo
Rio‘s ‘Christ the Redeemer‘ Statue Outfitted with Doctor‘s Coat in Tribute to Healthcare Workers https://t.co/gdTGm9G1zf via @BreitbartNews
View on Twitter
0
0
Joseph Gulfo, MD Joseph Gulfo, MD ·
@josephgulfo
Four Friars Commemorate Good Friday on Jerusalem’s Via Dolorosa https://t.co/qfOaQD2N31 via @BreitbartNews
View on Twitter
0
0
Follow @josephgulfo
Proudly powered by WordPress

Pin It on Pinterest